Literature DB >> 23133205

Role of proliferative markers in breast lesions.

Asim Kumar Manna1, Swapan Pathak, Diptendra Kumar Sarkar.   

Abstract

BACKGROUND: Carcinoma of breast is a leading cause of death in women throughout the world. Difficulty in diagnosis occurs in routine Hematoxylin and Eosin (H&E) stained sections to differentiate premalignant lesions like epitheliosis and malignant lesions like carcinoma in situ which may affect prognosis. AIMS: Our study was done to assess the role of proliferative markers in this field.
MATERIALS AND METHODS: In this study, total 66 cases of different breast lesions were studied by H&E stained sections as well as proliferative markers like silver staining nucleolar organizer region (AgNOR) and proliferating cell nuclear antigen (PCNA).
RESULTS: Statistically significant differences found in expression of proliferative markers between most of them.
CONCLUSION: Study of proliferative markers help in the proper diagnosis of different breast lesions which lies in the grey zone on routine histopathology.

Entities:  

Keywords:  Breast lesions; Proliferative markers

Year:  2010        PMID: 23133205      PMCID: PMC3452539          DOI: 10.1007/s12262-010-0010-y

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  7 in total

1.  Nucleolar organizer regions distribution in fine needle aspiration cytological smears from breast lesions.

Authors:  J Hasnan; G Jayaram
Journal:  Malays J Pathol       Date:  1996-06       Impact factor: 0.656

2.  Argyrophilic Nucleolar Organizer Regions of Breast Tumors: Assessment of Aspirated Cytological Materials.

Authors: 
Journal:  Breast Cancer       Date:  1996-12-20       Impact factor: 4.239

3.  Correlation of the growth fraction, nucleolar organizer region counts and epidermal growth factor receptor with histomorphological prognostic criteria in breast cancer.

Authors:  G R Gupta; B N Datta; S M Bose; K Joshi
Journal:  Indian J Pathol Microbiol       Date:  1997-01       Impact factor: 0.740

4.  Proliferating activity in differential diagnosis of benign phyllodes tumor and cellular fibroadenomas: is it helpful?

Authors:  R Kaya; H E Pestereli; G Erdogan; K H Gülkesen; S Karaveli
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

5.  Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast.

Authors:  T Tanaka; M Kimura; K Matsunaga; D Fukada; H Mori; Y Okano
Journal:  Cancer Res       Date:  1999-05-01       Impact factor: 12.701

6.  Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma.

Authors:  H F Frierson; R A Wolber; K W Berean; D W Franquemont; M J Gaffey; J C Boyd; D C Wilbur
Journal:  Am J Clin Pathol       Date:  1995-02       Impact factor: 2.493

7.  Proliferating cell nuclear antigen in benign breast diseases.

Authors:  M R Cardillo; G W Stamp; M Pignatelli
Journal:  Eur J Gynaecol Oncol       Date:  1995       Impact factor: 0.196

  7 in total
  1 in total

1.  Morphometric and histological study of breast lesions with special reference to proliferative activity and invasiveness.

Authors:  Asim Kumar Manna; Aparajita Samaddar; Sumit Mitra; Swapan Pathak; Srabani Chakrabarti; Diptendra Kumar Sarkar
Journal:  Indian J Surg       Date:  2012-04-14       Impact factor: 0.656

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.